Samsung Biologics buys Swiss peptide maker for $1.8bn

4 days ago

PolyPeptide takeover is latest example of South Korean companies expanding abroad through acquisitions
Click here to Read More
Previous Article
China’s ‘national team’ buys shares worth $9bn to prop up market
Next Article
British YouTuber Yung Filly fronts Australian court over rape allegations

Related Finance Updates:

Are you sure? You want to delete this comment..! Remove Cancel

Comments (0)

    Leave a comment